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die early of massive PTE, delayed death may result from
recurrence of previously silent, unsuspected PTE.7 This
fact emphasizes the importance of correct diagnosis,
because an adequate anticoagulant therapy reduces the
mortality rate to 2.5% to 3.0%.7-9
Because PTE is still an underdiagnosed disorder10 and
strategies of therapy should be adapted to the extension of
the thrombotic disease, finding positive evidence of PTE
may be a critical point to ensure adequate therapy. Two
common mistakes should be avoided: the first is under-
treatment of silent embolism, and the second is aggressive
treatment of presumed progression of PTE. On the other
hand, the morphologic changes directly available on spiral
CT arteriograms are expected to improve our knowledge
on the evolution of PTE. We performed a prospective
study with objective low-cost and low-risk diagnostic
methods used with the aim to evaluate the prevalence,
evolution, and possible therapeutic implications of silent
PTE in the course of acute DVT of lower limbs.
PATIENTS, MATERIALS, AND METHODS
From January 1998 to December 1999, 162 consecu-
tive patients with symptomatic acute lower limb DVT that
was confirmed by duplex examination in our vascular lab-
oratory and no pulmonary artery symptoms were consid-
ered for entry into the study. Patients were excluded if
they had hypersensitivity to intravenous contrast material
The incidence of deep vein thrombosis (DVT) in the
United States is about 159 per 100,000, or about 398,000
per year. The overall incidence of pulmonary embolus (PE)
is about 139 per 100,000, or 347,000 per year (clinical
data) and about 235,000 deaths per year (autopsy data).1
Both locations, lower limb and pulmonary, are manifesta-
tions of venous thromboembolic disease, and the expres-
sion pulmonary thromboembolism (PTE) includes the PE
and the thrombus formed in the pulmonary arterial tree,
two entities clinically not distinguished.2
Symptoms and signs of PTE are nonspecific, and no
laboratory tests provide accurate evidence, thus their diag-
nosis relies heavily on imaging techniques.3 Spiral com-
puted tomographic (CT) pulmonary angiography is a new,
highly sensitive strategy for detecting PTE.2,4,5
Untreated, clinically apparent PTE has been associated
with a 30% hospital mortality rate.6 In patients who do not
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Purpose: This study was carried out to evaluate the prevalence and extension of pulmonary thromboembolism (PTE) in
symptom-free patients with symptomatic deep venous thrombosis (DVT) of lower limbs and to evaluate their possible
implication in the adequate treatment of thromboembolic disease.
Material and Methods: We prospectively studied, using noninvasive examination (pulmonary spiral computed tomogra-
phy [CT] angiography), 159 consecutive patients with acute DVT confirmed by duplex scanning without symptoms of
PTE. CT was repeated at 30 days to study evolution of these clinically occult PTE.
Results: We observed silent PTE in 65 patients (41%) in all levels of lower limb venous thrombosis. Prevalence of PTE
showed significant association with male sex (P = .001) and previously diagnosed heart disease (P = .023). There was
no significant association between the level of DVT and the presence of PTE nor the DVT side and thromboembolic
pulmonary localization. Of the 65 patients with positive CT exploration results for PTE, 52 had characteristics of acute
PTE, 10 had chronic PTE, and 3 patients had both. Chronic PTE was found more frequently in patients with previ-
ous episodes of DVT (P = .024). A total of 165 pulmonary artery–affected segments were found at several locations:
5 main, 35 lobar, 58 interlobar, and 67 segmental. Multiple segments were affected in 59% of patients. Repeat CT
examinations were performed at 30 days in 53 of 65 patients with positive CT scanning results. In 48 cases (90.6%)
PTE had completely disappeared.
Conclusions: Silent PTE occurred frequently in association with clots of lower limbs. The CT scan had a good avail-
ability and cost-effectiveness to detect clinically underestimated PTE. The incorporation of this exploration in the sys-
tematic diagnostic strategy of most patients with DVT to establish the extension of thromboembolic disease at
diagnosis may be useful in the evaluation of added pulmonary artery symptoms and treatment strategies. (J Vasc Surg
2001;33:515-21.)
or impaired renal function or were pregnant. Patients
appropriate for the study were asked to give their
informed consent and were evaluated with CT within 24
hours after undergoing duplex venous examination.
Duplex venous examinations were performed with a
Philips P-700 duplex scanner (Philips, Santa Ana, Calif),
with a 5- to 7.5-MHz probe. Iliac, common femoral,
superficial femoral, popliteal, tibial, and peroneal veins
were routinely examined. The standard findings of incom-
pressibility and absent or diminished Doppler signals were
analyzed.12
CT scans were performed by use of the spiral tech-
nique with an X-press GX helical scan (Toshiba, Otawara-
Shi, Japan), during a single breath-hold period. The entire
lung was initially examined by contiguous 5- to 7-mm no-
contrast scans through the thorax to identify pleural or
parenchymal disease. A low-osmolarity, 30% iodinated
nonionic contrast agent 120 to 150 mL was administered
into a peripheral vein with an automatic injector at a rate
of 3 to 4 mL/s. After administration of contrast, cranio-
caudal scanning from the level of the aortic arc to the infe-
rior pulmonary veins with 3-mm sections followed by
5-mm sections to the lung bases reconstructed every 4
mm was done to evaluate the pulmonary arterial tree.13
The subsegmental level was visualized when possible but
not scored for this study because of the lower sensitivity of
spiral CT at this location.5,14
The CT exploration is considered positive for pul-
monary thromboembolism solely on the basis of the pres-
ence of one or more intraluminal filling defects in the
pulmonary arteries3 or complete/incomplete obstruc-
tion.4,9,15 In our institution, sensitivity of CT for diagno-
sis of PTE is 86.7%, the specificity is 96.5%, the positive
predictive value is 94.8%, and the negative predictive value
is 90.3%.
PTEs were classified as acute (filling defect was viewed
with contrast tracking around the defect) and chronic
(eccentric thrombus continuous with the vessel wall).16 The
pulmonary PTE localization (main, lobar, interlobar and
segmental), side, and number of PTE segments were regis-
tered. Other thoracic findings were recorded separately.
The explorations were examined by two radiologists,
one of whom was not involved in the study. The overall
quality of the CT images was judged to be adequate for
interpretation in all patients. In one woman who was
unable to hold her breath, although the quality of the
images was reduced, it was good enough for evaluation.
Concordance between observers was evaluated with the
kappa index. Kappa index for PE reached 0.940. Kappa
index for central versus peripheral PE was 0.938.
Pulmonary arteriography was not used to confirm
PTE found in CT scanning because this exploration is
invasive, and we decided that the added risk was not justi-
fiable in symptom-free patients. Angiography was reserved
for patients with development of pulmonary-related symp-
toms after initiation of therapy.
The second aim of this study was to observe the evo-
lution of the PTE. Thus a repeat pulmonary CT scan was
performed at 30 days’ follow-up in patients with positive
initial CT results and at any time thereafter if symptoms
developed. The findings were scored according to the
quantitative (number of segments affected) and qualitative
(resolving clots were seen as eccentric wall-adherent filling
defect or filling defects with central contrast material) evo-
lution compared with baseline CT and summarized as nor-
malized, improved, unchanged, or deteriorated.
The cost of each diagnostic CT procedure was calcu-
lated by use of local public hospital cost accounting data,
including personnel cost (physicians, nurses, technicians,
administrative), equipment cost (maintenance, deprecia-
tion, housekeeping, management), supplies and devices
(catheter, contrast material, photographic material), and
service costs (installations, sterilization, telephones). The
total cost was divided by the total number of CT explo-
rations performed in the Radiology Department.
All patients were treated after diagnosis of DVT with a
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Table I. Risk factors and predisposing conditions according to the ISCVS/NAC classification and incidence of occult
PTE in patients with DVT
Score
No. of patients (PTE cases ) 0 1 2 3 4 P value
Prior history of DVT 133 (55) 3 (1) 19 (8) 4 (4) NA ns
Immobilization 105 (45) 1 (1) 53 (22) 0 NA ns
Postoperative state 137 (59) 2 (1) 7 (3) 13 (5) NA ns
Age (y) 17 (3) 63 (26) 79 (39) NA NA ns
Malignancy 127 (56) 27 (9) 0 5 (3) NA ns
Tissue type of malignancy 137 (60) 22 (8) NA NA NA ns
Heart disease 155 (90) 2 (2) 2 (2) 0 NA ns
Limb trauma 147 (65) 4 (1) 3 (1) 3 (0) 2 (1) ns
Prethrombotic state 128 (57) 23 (9) 3 (1) 5 (1) NA ns
Hormonal therapy 148 (64) 11 (4) NA NA NA ns
Pregnancy and postpartum state 158 (68) 1 (0) NA NA NA ns
Obesity 141 (64) 18 (4) NA NA NA ns
No. total patients = 159. No. total of PTE = 68 (55 acute + 13 chronic).
NA, Not applicable; ns, not significant.
low-molecular-weight heparin, nadroparin calcium (Fraxi-
parine) administered subcutaneously twice at day with a
fixed dose adjusted to body weight. Anticoagulation with
nadroparin or acenocoumarol (Sintrom) was continued for
at least 3 months. Elastic stockings were provided in all
cases. No surgical interventions were carried out.
Statistical analysis was performed with the SPSS 8.0
statistical package (SPSS Inc, Chicago, Ill) for Windows
98 and Microsoft Excel. A P value less than .05 was con-
sidered significant. The tests used were the χ2, the Fisher
exact test, and risk estimations for retrospective analysis of
factors.
RESULTS
Patients. During the 48 months of our study, 162
consecutive patients with DVT confirmed by use of duplex
scanning but without clinical evidence of PTE were con-
sidered for entry into the study. Of these eligible patients,
three were excluded, one because of oliguria (creatinine
level > 200 µmol/L), another because of previous severe
allergic reaction to intravenous contrast medium, and one
because of pregnancy.
The 159 patients included in the study ranged in age
from 17 to 91 years (mean, 63.8 years). The group was
composed of 71 (44.6%) women and 88 (55.3%) men.
The thrombi involved the right limb side in 71 patients
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and the left side in 88. One hundred fifty-one patients
(95%) had proximal DVT: 75 iliofemoral, 50 femoro-
popliteal, and 26 popliteal. Infrapopliteal DVT was pres-
ent in eight (5%) patients.
Risk factors associated with DVT and PTE, according
to the classification of the Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter,17 are summarized in Table I.
PTE diagnosis. In 65 patients (40.9%) PTE was diag-
nosed: 52 had acute PTE, 10 had chronic PTE, and 3
patients had both. The influence of several characteristics
of patients and level of DVT in the diagnosis of occult
acute and chronic PTE are sumarized in Table II.
PTE was found more frequently in men (52.3%) (35
acute PTE, 8 chronic, and 3 both) than in women (26.8%)
(17 acute and 2 chronic PTE); the difference was statisti-
cally significant (P = .001). Acute PTE was associated with
previously diagnosed heart disease, irrespective of clinical
status (P = .023). The incidence of chronic asymptomatic
PTE was higher in patients with a history of DVT (P =
.024). In the positive CT study results for PTE, a total of
165 pulmonary segments showed clots: 5 main, 35 lobar,
58 interlobar, and 67 segmental localization (Table III).
PTE was observed in multiple segments in 58.8% of
pathologic CT examinations. The number of segments
affected was distributed as follows: one segment in 26 of
Table II. Risk factors and DVT characteristic conditions associated with silent PTE in patients with DVT
Characteristics No. of patients Acute PTE P value OR Chronic PTE P value OR
Age
< 40 y 17 3 ns 0 ns
41-70 63 19 ns 7 ns
> 71 79 33 ns 6 ns
Sex
Male 88 38 .011 2.41 11 .039 4.93
Female 71 17 .011 0.41 2 .039 0.2
DVT level
Iliofemoral 75 24 ns 8 ns
Femoropopliteal 50 20 ns 3 ns
Popliteal 26 8 ns 2 ns
Infrapopliteal 8 3 ns 0 ns
DVT side
Right 71 19 ns 8 ns
Left 88 36 ns 5 ns
Risk factors
History of DVT 23 8 ns 5 .024 4.44
Immobilization 54 20 ns 3 ns
Postoperative state 22 8 ns 1 ns
Malignancy 32 11 ns 1 ns
Adenocarcinoma 22 7 ns 1 ns
Previous cardiac disease 26 14 .023 2.69 2 ns
Previous chronic lung disease 11 6 ns 0 ns
Limb trauma 12 3 ns 0 ns
Hypercoagulability status diagnosed 10 (36)* 3 ns 0 ns
Hormonal therapy 11 3 ns 1 ns
Pregnancy 1(15)† 0 0
Obesity 18 3 ns 1 ns
No. total patients = 159. No. total of PTE = 68 (55 acute + 13 chronic).
*10 of 36 hypercoagulability studies.
†1 of 15 women < 50 years.
65 patients (40%); two segments in 30 (46.1%); three seg-
ments in 6 (9.2%); four segments in 2 (2.1%); five seg-
ments in 0; and six segments in 1 (1.5%).
Thromboembolism was found more frequently on the
right pulmonary side (64.6%). The side and extent of
DVT were not associated with PTE side.
Other pulmonary pathologic findings were observed
in 44 (27.5%) CT explorations. Twenty-two were unre-
lated to PTE, and 22 were associated with PTE. No
parenchymal or pleural findings at CT were associated
with existence of PTE (Table IV).
The cost of CT was $50.17 per test (8529 pesetas).
Because 159 patients were studied, total cost of thoracic CT
would be 1,356,111 pesetas. The cost ratio of each PTE
diagnosed was $123 (20,863 pesetas) in the study group.
Clinical evolution. During the study period two
patients (1.2%) had development of thoracic pain
episodes: a 37-year-old man with iliofemoral DVT and
normal initial CT scanning results at the second day of
treatment and a 65-year-old man with femoropopliteal
DVT and left segmental PTE at the eighth day of antico-
agulation. A repeat CT scan result was normal in both
patients, and the pulmonary angiography showed no evi-
dence of any PTE.
PTE. At the final time point, 1 month after diagnosis,
CT scanning was performed in 53 of 65 patients with PTE
(81.5%). In 48 cases (90.6%) CT showed that pulmonary
thromboses had completely dissappeared. Residual throm-
bus, improved with respect to baseline CT, was found in
five explorations (9.4%) (Table V): three patients with
acute PTE showed a reduction in the number of affected
segments compared with initial examinations, and two
patients with chronic PTE showed significantly decreased
clot size. Two patients showed previous acute multiseg-
mental bilateral PTE, one previous main and right interlo-
bar PTE, and in two patients chronic thromboembolism
was diagnosed. All residual PTE was found in patients
receiving long-term oral anticoagulant treatment (98
patients), but the difference with treatment with low-mol-
ecular weight heparin (LMWH) (61 patients) was not sig-
nificant (P = .085).
DISCUSSION
Some noninvasive, rapid, low-cost, and easy methods
are being used with increasing frequency to allow greater
accuracy in diagnosis of DVT and PTE with minimum dis-
comfort for patients to avoid the difficulties of clinical diag-
nosis of venous thromboembolic disease resulting from
nonspecific symptoms.18,19 In this study we used objective
methods for clot detection. Diagnosis of leg thrombosis
was confirmed by duplex examination, and PTE was
detected by spiral CT scanning. Duplex scanning has a 94%
sensitivity and almost 100% specificity in patients with
symptomatic proximal DVT.5 Recently, sensitivity of color
flow Doppler ultrasound scanning for infrapopliteal DVT
has been reported to be as high as 98%.20
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Table III. Location of pulmonary segments involved by thromboembolism according to lower limbs thrombosis level
DVT
Iliofemoral Femoropopliteal Popliteal Infrapopliteal Total
Acute PTE
Main 1 2 0 0 3
Lobar 13 14 3 0 30
Interlobar 24 17 4 1 46
Segmental 23 21 11 2 57
Total (%) 61 (44.8) 54 (39.7) 18 (13.2) 3 (2.2) 136
Chronic PTE
Main 2 0 0 0 2
Lobar 2 1 2 0 5
Interlobar 9 1 2 0 12
Segmental 5 5 0 0 10
Total (%) 18 (62) 7 (24.1) 4 (13.7) 0 29
Pulmonary segments 79 (47.8) 61 (36.9) 22 (13.3) 3 (1.8) 165
Table IV. Frequency of pulmonary pathology in CT
examinations
PP PP + PTE
Malignancy (n = 10)
Lung cancer 3 1
Metastasis breast cancer 1 2
Metastasis prostate cancer 0 1
Lymph nodes 1 1
Lung disease (n = 20)
Infarction 0 2
Pneumonia 2 3
Fibrosis 2 0
Postradiation pneumonitis 1 0
Tuberculosis 1 1
Bronchiectasis 2 2
Bullae 0 1
Hypertension 1 2
Miscellanea (n = 14)
Nonspecific lymph nodes 4 0
Pleural effusion 2 4
Hiatal hernia 1 1
Constricting pericarditis 0 1
Thoracic aortic aneurysms 1 0
PP, Pulmonary pathology.
Our institution’s CT sensitivity, specificity, positive
predictive value, and negative predictive value for diagno-
sis of PTE with spiral CT angiography in main, lobar, and
segmental pulmonary arteries were in accordance with
described in the literature.3-5,15,21,22 Sensitivity is lower
when pulmonary emboli are confined to subsegmental
pulmonary arteries,14 but the clinical significance of such
lesions remains unclear19 and probably has limited clinical
importance.23
Spiral CT scanning has the additional advantage of
assessing the pulmonary parenchyma and the vasculature
of the lung and also allows evaluation of the mediastinum.
In 27.5% of patients, abnormalities other than PTE were
found in association with or independent of thromboem-
bolism, a similar incidence to what has been previously
reported.3
In our patients, we found that 41% had silent throm-
boembolic pulmonary affectation, higher than the 0% to
12% PTE incidence detected with perfusion lung scanning
studies performed in clinically symptom-free volunteers24
and the 1% of incidental pulmonary emboli detected in
patients who underwent thoracic helical CT scanning.25
Our results are consistent with the higher incidence of
occult PTE in patients with DVT reported in the literature,
between 34% and 50% detected with ventilation/perfusion
lung scanning26-30 and 34% to 47.1% with CT scan-
ning.9,31
Experimental pulmonary artery occlusion in animals
and known effects after pneumonectomy have shown that
a significant proportion of the pulmonary vascular bed
must be occluded before a significant change in pul-
monary artery pressure or cardiac output occurs.32 The
individual and unpredictable response to occlusion of pul-
monary vasculature, which depends more on the increase
in vascular resistance and cardiopulmonary reserve before
the thromboembolic event2 than on the extension and
location of clot, may explain the high incidence of PTE in
our patients without pulmonary symptoms, even with
major radiologic findings or previously diagnosed heart
disease in whom a lower cardiac reserve was presumed.
Our results confirm that no correlation exists between
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location, extent of thrombi, and clinical pulmonary symp-
toms.9,29
Although the prevalence related to sex is unclear in the
literature,33,34 PTE and death were usually reported to be
more frequent in men.35,36 In our study male sex was
found to be a risk factor for PTE, but we have no expla-
nation for that.
Silent PTE was most often found in the lower lung
lobes and in the right lung, according to previous
reports37; probably this may have been due to simply
anatomic reasons. When a large primary thrombus is
formed in the pulmonary tree or an embolus dislodges
from its site of origin and is carried through the venous
system and the right side of the heart to the pulmonary
arterial circulation, it may stop at the bifurcation of the
pulmonary trunk. The embolus may also become frag-
mented in the right ventricle, which results in multiple
smaller emboli. We found five main PTE, but the multiple
segment location was the most common finding in our
study.
The association between DVT and PTE has long been
recognized,18,38 and frequently they have been viewed as
distinct clinical entities, but nowadays the two conditions
are considered to be different expressions of the same
thromboembolic disease.5,9,11,19,28,32 In our study, all
patients were given LMWH when DVT was confirmed,
because we think that it is the presence of clot, irrespective
of their level or extension, that leads to indication for anti-
coagulation.
A greater, but not statistically significant, incidence of
affected pulmonary segments was found in iliofemoral and
femoropopliteal DVT localizations (48% and 37%, respec-
tively). Previous studies with other diagnosis methods
indicate that thrombi limited to the calf rarely result in
pulmonary emboli,39,40 and this location has been com-
monly considered a benign condition concerning this
complication. Although PTE were found in our observa-
tions in only 2.2% of calf DVT cases, these data indicate
that a low but significant risk of PTE definitely exists and
seem to indicate that all distal DVT should be treated, as
long as further investigations do not show with firm data
Table V. Persistent PTE findings in five patients undergoing follow-up CT scanning
Sex Age Risk factors PTE Localization Initial CT Control CT
M 75 Unknown Acute Bilateral Main bilateral
Right (interlobar, apical segment 
of upper lobe)
Segmental branches of lower lobe Right (segmental 
branches of lower lobe)
Left (descending, segmental branches 
of lower lobe)
M 76 Malignancy Chronic Right Right main Right main
M 76 Heart disease Chronic Left Segmental branches of upper lobe Segmental branches of 
upper lobe
F 86 Heart disease Acute Bilateral Right (interlobar) Right (interlobar)
Left (descending, segmental branches 
of upper lobe)
M 72 Hypertension Acute Right Right (main, interlobar) Right (interlobar)
that these PTE resolve spontaneously, do not recur, and
are not relevant for the patient’s outcome without antico-
agulation therapy. Accurate evaluation of pulmonary ves-
sels may be an important aid to avoid undertreatment in
isolated calf vein thrombosis when the indication of anti-
coagulation or decision to discontinue treatment was
based solely on the aisle and distal DVT location.
CT and pulmonary angiography performed 8 days
after initial diagnosis showed complete resolution of a pre-
viously diagnosed segmental PTE in one symptom-free
patient in whom symptoms developed during anticoagula-
tion. We have interpreted that as quick resolution of
thrombus in pulmonary vessels; thus this probably implies
that when correctly diagnosed and treated, PTE is not as
lethal as previously considered, but rather it follows a favor-
able course, as previously was hypothesized.5,25,28,41,42 At
1 month follow-up, CT studies performed in patients with
PTE showed resolution or reduction of the thrombi.43,44
Previous studies had reported the efficacy of
nadroparin in the initial treatment of pulmonary throm-
boembolism.45,46 Our results suggest that PTE evolution
was probably more favorable when LMWH rather than
oral anticoagulant was used for long-term therapy, but
because the study was not designed to compare two treat-
ment regimens, further studies will be necessary to con-
firm these findings.
Although the optimal duration of the secondary pre-
vention therapy is not yet established, we adjust this dura-
tion according to the presence of temporal, persistent, or
unknown risk factors.47 The quick PTE resolution found
before the end of the scheduled long-term therapy course
seems to indicate that the presence of pulmonary affecta-
tion alone should not necessarily influence the duration of
anticoagulation.
Frequently, patients having a recent history of DVT
who have chest pain or respiratory symptoms are assumed
to have PTE. These patients are at definite risk for being
overtreated if the pulmonary symptoms are erroneously
attributed to failure of anticoagulant treatment. Having an
initial CT examination makes interpretation of these respi-
ratory symptoms much easier. Perhaps chest pain may be
due to pleural irritation from a previous PTE being pres-
ent before treatment or other abnormalities. Measures
such as avoiding smoking, administering antibiotics for
lung infections, or treating hiatal hernia to avoid risk of
microaspirations should be established, rather than assum-
ing that therapy has failed and then overtreating the
patient with measures such as long-term/permanent anti-
coagulation or placing a filter into his vena cava.
Because CT scanning allows us to perform serial lung
studies while maintaining low complication rates, this pro-
cedure may be used to evaluate medical, radiologic, or
surgical alternative treatments for thromboembolic dis-
ease, as well as different modalities of medical therapy (eg,
daily or twice daily LMWH administration).
CT scanning is permanently available in our hospital
(Spanish National Health Service) and had a low cost;
thus, we considered it as an approach that accomplishes
the desired diagnostic effect with low cost (cost minimiza-
tion).48 Incorporation of CT scanning exploration is a
safe, cost-effective, and useful alternative in our systematic
diagnostic strategy of patients with DVT to determine the
extent of the thrombotic disease at initial diagnosis.
Because there were considerable international differ-
ences in costs of diagnostic procedures,49 the implications
of our results for routine clinical practice will be depen-
dent on the availability of equipment, patient outcomes,
and specific costs involved in each hospital.
We acknowledge the collaboration of Gloria Lozano
and Adela Martinez, Vascular Laboratory technicians, and
the secretarial assistance of Rosa Bernardo.
REFERENCES
1. Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability:
congenital and acquired causes of thrombosis. Med Clin North Am
1998;82:409-58.
2. Christiansen F. Diagnosis imaging of acute pulmonary embolism. Acta
Radiol Suppl 1997;410:1-33.
3. van Rossum AB, Treurniet FE, Kieft GJ, Smith SJ, Schepers-Bok R.
Role of spiral volumetric computed tomographic scanning in the assess-
ment of patients with clinical suspicion of pulmonary embolism and an
abnormal ventilation/perfusion lung scan. Thorax 1996;51:23-8.
4. Rémy-Jardin M, Rémy J, Wattinne L, Giraud F. Central pulmonary
thromboembolism: diagnosis with spiral volumetric CT with the sin-
gle-breath-hold technique—comparison with pulmonary angiogra-
phy. Radiology 1992;185:381-7.
5. van Erkel AR, van Rossum AB, Bloem JL, Kievit J, Pattynama PM.
Spiral CT angiography for suspected pulmonary embolism: a cost-
effectiveness analysis. Radiology 1996;301:29-36.
6. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog
Cardiovasc Dis 1975;17:259-63.
7. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI,
et al. The clinical course of pulmonary embolism. N Engl J Med
1992;326:1240-5.
8. Alpert JS, Smith R, Carlson J, Ockene IS, Dexter L, Dalen JE. Mortality
in patients treated for pulmonary embolism. JAMA 1976;236:
1477-80.
9. Gouzien P, Chabierski M, Baccialone J, Jeanbourquin D.
Asymptomatic pulmonary embolism and venous thrombosis of the
lower limbs: study with spiral x-ray computed tomography [French].
J Radiol 1996;77:125-8.
10. Morpurgo M, Schmid C. The spectrum of pulmonary embolism: clin-
icopathologic correlations. Chest 1995;107 Suppl:18S.
11. Turkstra F, Koopman MM, Buller HR. The treatment of deep vein
thrombosis and pulmonary embolism. Thromb Haemost 1997;78:
489-96.
12. Zwiebel WJ. Color duplex imaging and Doppler spectrum analysis:
principles, capabilities and limitations. Semin Ultrasound CT MR
1990;11:84-96.
13. Naidich DP, Müller NL, Zerhouni EA, Webb WR, Krinsky GA,
Siegelman SS. Pulmonary arteries and hila. In: Webb WR, Müller NL,
Naidich DP, editors. Computed tomography and magnetic resonance
of the thorax. Baltimore: Lippincott-Raven; 1998. p. 603-56.
14. Goodman LR, Curtin JJ, Mewissen MW, Foley WD, Lipchik RJ,
Crain MR, et al. Detection of pulmonary embolism in patients with
unresolved clinical and scintigraphic diagnosis: helical CT versus
angiography. AJR Am J Roentgenol 1995;164:1369-74.
15. Senac JP, Vernhet H, Bousquet C, Giron J, Pieuchot P, Durand G, et
al. Pulmonary embolism: contribution of spiral x-ray computed
tomography [French]. J Radiol 1995;76:339-45.
16. Teigen CL, Maus TP, Sheedy PF 2nd, Stanson AW, Johnson CM,
Breen JF, et al. Pulmonary embolism: diagnosis with contrast-
enhanced electron-beam CT and comparison with pulmonary angiog-
raphy. Radiology 1995;194:313-9.
17. Porter JM, Moneta GL. An international consensus committee on
JOURNAL OF VASCULAR SURGERY
520 López-Beret et al March 2001
chronic venous disease: reporting standards in venous disease: an
update. J Vasc Surg 1995;21:635-45.
18. Dorfamn GS, Cronan JJ, Tupper TB, Messersmith RN, Denny DF,
Lee CH. Occult pulmonary embolism: a common occurrence in deep
venous thrombosis. AJR Am J Roentgenol 1987;148:263-6.
19. Baker WF Jr. diagnosis of deep venous thrombosis and pulmonary
embolism. Med Clin North Am 1998;82:459-76.
20. Bradley MJ, Spencer PA, Alexander L, Milner GR. Colour flow map-
ping in the diagnosis of the calf deep vein thrombosis. Clin Radiol
1993;47:399-402.
21. Bongartz G, Boos M, Scheffler K, Steinbrich W. Pulmonary circula-
tion. Eur Radiol 1998;8:698-706.
22. ACCP Consensus Committee on Pulmonary Embolism. Opinions
regarding the diagnosis and management of venous thromboembolic
disease. Chest 1998;113:499-504.
23. Goodman LR, Lipchik RJ. Diagnosis of acute pulmonary embolism:
time for a new approach. Radiology 1996;199:25-7.
24. Wallace JM, Moser KM, Hartman MT, Ashburn WL. Pattern of pul-
monary perfusion scans in normal subjects. Am Rev Respir Dis
1981;124:480-3.
25. Winston CB, Wechsler RJ, Salazar AM, Kurtz AB, Spirn PW.
Incidental pulmonary emboli detected at helical CT: effect on patient
care. Radiology 1996;201:23-7.
26. Kistner RL, Ball JJ, Nordyke RA, Freeman GC. Incidence of pul-
monary embolism in the course of thrombophlebitis of the lower
extremities. Am J Surg 1972;124:169-76.
27. Moser KM, LeMoine JR. Is embolic risk conditioned by location of
deep venous thrombosis? Ann Intern Med 1981;94:439-44.
28. Huisman MV, Buller HR, ten Cate JW, van Royen EA, Vreeken J,
Kersten MJ, et al. Unexpected high prevalence of silent pulmonary
embolism in patients with deep venous thrombosis. Chest 1989;95:
498-502.
29. Hirsch JF, Demilly P. Screening of asymptomatic pulmonary
embolisms by systematic scintigraphy in apparently uncomplicated
phlebitis [French]. Ann Med Interne (Paris) 1991;142:160-70.
30. Pesavento R, Lusiani L, Visona A, Bonanome A, Zanco P, Perissinotto
C, et al. Prevalence of clinically silent pulmonary embolism in deep
venous thrombosis of the legs [Italian]. Minerva Cardioangiol
1997;45:369-75.
31. Paul JF, Hernigou A, Beyssen B, Froissart M, Fiessinger JN, Gaux JC.
Systematic screening of pulmonary embolism with spiral CT scanner
in patients with proximal deep vein thrombosis [French]. Presse Med
1999;28:633.
32. Traill ZC, GLeeson FV. Venous thromboembolic disease. Br J Radiol
1998;71:129-34.
33. Silverstein MC. Trends in the incidence of deep vein thrombosis and
pulmonary embolism: a 25-year population-based study. Arch Intern
Med 1998;155:585-93.
34. Stein PD, Huang H, Afzal A, Noor H. Incidence of acute pulmonary
embolism in a general hospital. Chest 1999;116:909-13.
JOURNAL OF VASCULAR SURGERY
Volume 33, Number 3 López-Beret et al 521
35. Soskolne CL, Wong AW, Lilienfeld DE. Trends in pulmonary
embolism death rates for Canada and the United States. CMAJ
1990;142:321-6.
36. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr.
The epidemiology of diagnosed pulmonary embolism and deep
venous thrombosis in the elderly. Arch Intern Med 1994;154:
861-6.
37. Godleski JJ. Pathology of deep venous thrombosis and pulmonary
embolism. In: Goldhaber SZ, editor. Pulmonary embolism and deep
venous thrombosis. Philadelphia: WB Saunders; 1985. p. 20-3.
38. A Collaborative Study by the PIOPED Investigators. Value of the ven-
tilation/perfusion scan in acute and pulmonary embolism: results of
the Prospective Investigation of Pulmonary Embolism Diagnosis
(PIOPED). JAMA 1990;263:2753-9.
39. Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of post-
operative deep vein thrombosis. Lancet 1969;2:230-2.
40. Moser KM, LeMoine JR. Is embolic risk conditioned by location of
deep venous thrombosis? Ann Intern Med 1981;94:439-44.
41. Stein PD, Henry JW, Relyea B. Untreated patients with pulmonary
embolism: outcome, clinical and laboratory assessment. Chest 1995;
107:931-5.
42. Smith TP. Pulmonary embolism: what’s wrong with this diagnosis?
AJR Am J Roentgenol 2000;174:1489-97.
43. Remy-Jardin M, Louvegny S, Remy J, Artaud D, Deschildre F,
Bauchart JJ, et al. Acute central thromboembolic disease: postthera-
peutic follow-up spiral CT angiography. Radiology 1997;203:
173-80.
44. Van Rossum AB, Pattynama PM, Tjin A, Ton E, Kieft GJ. Spiral CT
appearance of resolving clots at 6 week follow-up after acute pul-
monary embolism. J Comput Assist Tomogr 1998;22:413-7.
45. Thery C, Simonneau G, Meyer G, Helenon O, Bridey F, Armagnac
C, et al. Randomized trial of subcutaneous LMWH CY 216
(Fraxiparine) compared with intravenous unfractionated heparin in
the curative treatment of submassive pulmonary embolism: a dose
ranging study. Circulation 1992;85:1380-9.
46. Torbicki A, Pacho R, Jedrusik P, Pruszczyk P. Noninvasive Diagnosis
and treatment of a saddle pulmonary embolism: a case report in sup-
port of new trends in management of pulmonary embolism. Chest
1996;109:1124-6.
47. ten Cate JW, Koopman MM, Prins MH, Buller HR. Treatment of
venous thromboembolism. Thromb Haemost 1995;74:197-203.
48. Hull RD, Feldstein W, Pineo GF, Raskob GE. Cost effectiveness of
diagnosis of deep venous thrombosis in symptomatic patients.
Thromb Haemost 1995;74:189-96.
49. van Erkel AR, van der Hout WB, Pattynama PM. International dif-
ferences in health care cost in Europe and the United States: do these
affect the cost-effectiveness of diagnostic strategies for pulmonary
embolism? Eur Radiol 1999;9:1926-31.
Submitted Apr 10, 2000; accepted Jun 26, 2000.
